The Germany Embolotherapy Market Size is foreseen to grow from USD 170.1 Million in 2025 and is govern to reach around USD 351.1 Million by 2035. According to Decision Advisors, a detailed research report on the Germany embolotherapy market is boosted by a shift toward minimally invasive outpatient care, accounting for nearly up to the 30-40% share of the total share. Medtronic is the prime player in the market with approximately USD 190 Million in annual turnover and a 25-35% market share, positioning it as the primary driver of the Germany embolotherapy market.